For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Thailand Medical News  Jan 19, 2019  6 years, 10 months, 4 weeks, 8 hours, 42 minutes ago

NeuroMetrix Introduces AI for Pain Relief at CES 2019 with the debut of its Quell 2.0 TENS Device

NeuroMetrix Introduces AI for Pain Relief at CES 2019 with the debut of its Quell 2.0 TENS Device
Thailand Medical News  Jan 19, 2019  6 years, 10 months, 4 weeks, 8 hours, 42 minutes ago
Quell is a US FDA cleared, over-the-counter wearable therapeutic device for chronic pain. Transcutaneous electrical nerve stimulation (TENS) is a therapy that has been around for decades. It is used to treat pain and a few other conditions, but over those decades it has gotten a bit stale. New companies, though, are taking TENS therapy to a new level and NeuroMetrix is one of the leaders in this field .

NeuroMetrix Introduces AI for Pain Relief
The company was showing off for the first time its Quell 2.0 TENS device at CES 2019. It is smaller than the company’s original product, but sports a larger battery that can provide more juice and more therapy sessions per charge. It is actually more powerful than any other TENS device on the market and is about ten times more powerful than your typical over-the-counter TENS unit.
NeuroMetrix Introduces

The new Quell 2.0 also comes with new capabilities through the companion app that provides coaching and helps to optimize therapy. There’s also an “Intensive Therapy” option that apparently users machine learning to best match therapy to the individual patient’s needs.

For more info, visit the company’s website at https://www.neurometrix.com/

MOST READ

Dec 11, 2025  6 days ago
Nikhil Prasad
Dec 10, 2025  6 days ago
Nikhil Prasad
Dec 09, 2025  8 days ago
Nikhil Prasad
Dec 07, 2025  10 days ago
Nikhil Prasad
Dec 01, 2025  16 days ago
Nikhil Prasad
Nov 28, 2025  19 days ago
Nikhil Prasad
Nov 26, 2025  20 days ago
Nikhil Prasad
Nov 24, 2025  23 days ago
Nikhil Prasad
Nov 23, 2025  23 days ago
Nikhil Prasad
Nov 23, 2025  23 days ago
Nikhil Prasad
Nov 19, 2025  27 days ago
Nikhil Prasad